Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deal Details 15
Partnerships 15
DefiniGen Enters into Licensing Agreement with Broad Institute 15
Beam Therapeutics Enters into Licensing Agreement with Broad Institute 16
Eisai Enters into Research Agreement with Broad Institute, Colorado State University and University of Chicago 17
Eisai Enters into Research Agreement with Broad Institute 18
Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 19
Broad Institute Genomic Services Partners with Takeda Pharma 20
Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 21
Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 22
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 23
Eisai Enters into Research Agreement with Broad Institute 24
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 25
EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 26
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 27
Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 29
Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 30
AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 31
Licensing Agreements 32
Celsius Therapeutics Enters into Licensing Agreement with Broad Institute 32
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 33
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 35
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 37
Applied Stemcell Enters into licensing Agreement with Broad Institute 39
Albany Molecular Research Enters into Licensing Agreement with Broad Institute 40
Evotec Enters into Licensing Agreement with Broad Institute 41
Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 42
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 43
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 44
GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 45
Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 46
Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 47
Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 48
The Broad Institute Inc – Key Competitors 49
The Broad Institute Inc – Key Employees 50
The Broad Institute Inc – Locations And Subsidiaries 51
Head Office 51
Other Locations & Subsidiaries 51
Recent Developments 52
Strategy And Business Planning 52
Oct 10, 2017: Broad Institute launches Merkin Institute for Transformative Technologies in Healthcare 52
Legal and Regulatory 53
Sep 13, 2018: US Appeals Court upholds ruling on CRISPR patents in favour of Broad Institute 53
Government and Public Interest 55
Sep 10, 2018: Protein analysis uncovers new cancer subtypes for medulloblastoma 55
Aug 15, 2018: New genome analysis scores risk of serious common diseases 57
Jul 24, 2018: Researchers identify immune system mechanism that regulates inflammation 58
Apr 24, 2018: A Leading Method in Human Genetics Studies May Need to Be Reconsidered, as Researchers Discover Significant Distortions 59
Apr 02, 2018: Disease-Causing Mobile Element Identified with SMRT Sequencing, Validated with CRISPR 60
Mar 19, 2018: Metastatic Prostate Cancer Project Explores a New Approach to Genomics Research 61
Dec 20, 2017: CRISPR therapy preserves hearing in progressive deafness model 63
Sep 28, 2017: Neuro-Immune Crosstalk in Allergic Asthma 65
Product News 67
May 18, 2017: Cohen Veterans Bioscience and the Broad Institute’s Stanley Center for Psychiatric Research with PTSD researchers from the Psychiatric Genomics Consortium Announce Initial Findings from Largest Study of Genetic Markers for Post-Traumatic Stress Disorder 67
Jan 09, 2018: Broad Institute releases open-source GATK4 software for genome analysis, optimized for speed and scalability 68
Other Significant Developments 70
Aug 13, 2018: Predicting risk for common deadly diseases from millions of genetic variants 70
Jul 10, 2017: Broad Institute of MIT and Harvard Joins Discussions to Create Worldwide CRISPR-Cas9 Licensing Pool 72
May 24, 2017: BGI to work with Broad Institute, Intel and Alibaba Cloud to provide free access to GATK4 on BGI Online 73
Appendix 74
Methodology 74
About GlobalData 74
Contact Us 74
Disclaimer 74
The Broad Institute Inc, Pharmaceuticals & Healthcare, Key Facts 2
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
The Broad Institute Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
The Broad Institute Inc, Deals By Therapy Area, 2012 to YTD 2018 10
The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
DefiniGen Enters into Licensing Agreement with Broad Institute 15
Beam Therapeutics Enters into Licensing Agreement with Broad Institute 16
Eisai Enters into Research Agreement with Broad Institute, Colorado State University and University of Chicago 17
Eisai Enters into Research Agreement with Broad Institute 18
Cohen Veterans Bioscience Partners with Stanley Center for Psychiatric Research 19
Broad Institute Genomic Services Partners with Takeda Pharma 20
Beryllium Enters into Development Agreement with Broad Institute for MCL-1 platform 21
Bayer HealthCare Expands Co-Development Agreement with Broad Institute for Cardiovascular Therapies 22
AstraZeneca Enters into Research Agreement with Broad Institute and Whitehead Institute 23
Eisai Enters into Research Agreement with Broad Institute 24
Tetra Discovery Enters Into Co-Development Agreement With Stanley Center For Schizophrenia Therapeutics 25
EMD Serono Enters Into Research Agreement With Pfizer And Broad Institute 26
Massachusetts General Hospital Enters Into Collaboration Agreement With Broad Institute And Amgen For Drug Discovery 27
Eisai Enters Into Co-Development Agreement With Broad Institute For Neglected Tropical Diseases And Tuberculosis 29
Bayer HealthCare Pharma And Broad Institute Enter Into Agreement To Develop Cancer Therapy 30
AstraZeneca And Broad Institute Partner To Advance Discovery Of Antibacterial And Antiviral Agents 31
Celsius Therapeutics Enters into Licensing Agreement with Broad Institute 32
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 33
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, Massachusetts Institute of Technology and University of Iowa 35
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard University, and Massachusetts Institute of Technology 37
Applied Stemcell Enters into licensing Agreement with Broad Institute 39
Albany Molecular Research Enters into Licensing Agreement with Broad Institute 40
Evotec Enters into Licensing Agreement with Broad Institute 41
Transposagen Biopharma Enters into Licensing Agreement with Broad Institute 42
Neon Therapeutics Enters into Licensing Agreement with Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital 43
Sigma Life Science Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 44
GE Healthcare Life Sciences Enters into Licensing Agreement with Broad Institute for Crispr Gene Engineering System 45
Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 46
Sage Labs Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 47
Horizon Discovery Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System 48
The Broad Institute Inc, Key Competitors 49
The Broad Institute Inc, Key Employees 50
The Broad Institute Inc, Other Locations 51
The Broad Institute Inc, Subsidiaries 51
List of Figures
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
The Broad Institute Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
The Broad Institute Inc, Medical Devices Deals, 2012 to YTD 2018 11